1. Home
  2. VRDN vs ALX Comparison

VRDN vs ALX Comparison

Compare VRDN & ALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • ALX
  • Stock Information
  • Founded
  • VRDN 2006
  • ALX 1928
  • Country
  • VRDN United States
  • ALX United States
  • Employees
  • VRDN N/A
  • ALX N/A
  • Industry
  • VRDN Medical Specialities
  • ALX Real Estate Investment Trusts
  • Sector
  • VRDN Health Care
  • ALX Real Estate
  • Exchange
  • VRDN Nasdaq
  • ALX Nasdaq
  • Market Cap
  • VRDN 1.3B
  • ALX 1.2B
  • IPO Year
  • VRDN N/A
  • ALX N/A
  • Fundamental
  • Price
  • VRDN $15.67
  • ALX $228.01
  • Analyst Decision
  • VRDN Strong Buy
  • ALX Sell
  • Analyst Count
  • VRDN 11
  • ALX 1
  • Target Price
  • VRDN $38.50
  • ALX $125.00
  • AVG Volume (30 Days)
  • VRDN 728.3K
  • ALX 77.9K
  • Earning Date
  • VRDN 08-07-2025
  • ALX 08-04-2025
  • Dividend Yield
  • VRDN N/A
  • ALX 7.74%
  • EPS Growth
  • VRDN N/A
  • ALX N/A
  • EPS
  • VRDN N/A
  • ALX 7.72
  • Revenue
  • VRDN $302,000.00
  • ALX $219,892,000.00
  • Revenue This Year
  • VRDN N/A
  • ALX N/A
  • Revenue Next Year
  • VRDN $17,102.33
  • ALX N/A
  • P/E Ratio
  • VRDN N/A
  • ALX $29.91
  • Revenue Growth
  • VRDN 4.86
  • ALX N/A
  • 52 Week Low
  • VRDN $9.90
  • ALX $184.76
  • 52 Week High
  • VRDN $27.20
  • ALX $251.63
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 61.91
  • ALX 59.30
  • Support Level
  • VRDN $13.84
  • ALX $222.50
  • Resistance Level
  • VRDN $14.85
  • ALX $231.23
  • Average True Range (ATR)
  • VRDN 0.82
  • ALX 5.25
  • MACD
  • VRDN -0.03
  • ALX -0.04
  • Stochastic Oscillator
  • VRDN 82.81
  • ALX 89.65

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About ALX Alexander's Inc.

Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.

Share on Social Networks: